| Schedule of revenue recognition |
| |
|
Three Months Ended September 30, |
|
| |
|
2020 |
|
|
2019 |
|
| Functional neurosurgery navigation |
|
|
|
|
|
|
|
|
| Disposable products |
|
$ |
1,840,060 |
|
|
$ |
1,854,251 |
|
| Therapy |
|
|
|
|
|
|
|
|
| Disposable products |
|
|
— |
|
|
|
64,095 |
|
| Services |
|
|
— |
|
|
|
50,000 |
|
| Subtotal – therapy revenue |
|
|
— |
|
|
|
114,095 |
|
| Biologics and drug delivery |
|
|
|
|
|
|
|
|
| Disposable products |
|
|
419,946 |
|
|
|
491,257 |
|
| Services |
|
|
1,054,622 |
|
|
|
72,500 |
|
| Subtotal – biologics and drug delivery revenue |
|
|
1,474,568 |
|
|
|
563,757 |
|
| Capital equipment and software |
|
|
|
|
|
|
|
|
| Systems and software products |
|
|
73,544 |
|
|
|
184,825 |
|
| Services |
|
|
131,015 |
|
|
|
210,538 |
|
| Subtotal – capital equipment and software revenue |
|
|
204,559 |
|
|
|
395,363 |
|
| Total revenue |
|
$ |
3,519,187 |
|
|
$ |
2,927,466 |
|
| |
|
Nine Months Ended September 30, |
|
| |
|
2020 |
|
|
2019 |
|
| Functional neurosurgery navigation |
|
|
|
|
|
|
|
|
| Disposable products |
|
$ |
4,573,484 |
|
|
$ |
5,212,460 |
|
| Therapy |
|
|
|
|
|
|
|
|
| Disposable products |
|
|
78,800 |
|
|
|
81,925 |
|
| Services |
|
|
25,000 |
|
|
|
200,000 |
|
| Subtotal – therapy revenue |
|
|
103,800 |
|
|
|
281,925 |
|
| Biologics and drug delivery |
|
|
|
|
|
|
|
|
| Disposable products |
|
|
1,000,276 |
|
|
|
957,673 |
|
| Services |
|
|
2,646,050 |
|
|
|
338,112 |
|
| Subtotal – biologics and drug delivery revenue |
|
|
3,646,326 |
|
|
|
1,295,785 |
|
| Capital equipment and software |
|
|
|
|
|
|
|
|
| Systems and software products |
|
|
377,445 |
|
|
|
700,517 |
|
| Services |
|
|
411,508 |
|
|
|
515,695 |
|
| Subtotal – capital equipment and software revenue |
|
|
788,953 |
|
|
|
1,216,212 |
|
| Total revenue |
|
$ |
9,112,563 |
|
|
$ |
8,006,382 |
|
|